Nmt Medical Inc. (MM (NASDAQ:NMTI) Last Price (USD) $0.7693 Change 0.0405 (5.56%) Bid 0.7651 Ask 0.7691 Volume 1,451,707 Days Range 0.74 - 0.8282 Last Trade 6/21/2010 11:50:25 AM
Yes just as you posted i was reading the 13G and watched if its listed at www.insidercow.com Sellers should be out now. IMO !
S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 341,938 $0.69 $236,963.00 1,127,420 view S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 240,000 $0.65 $156,000.00 1,469,360 view S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 400,000 $0.68 $271,760.00 1,709,360 view S 2010-06-18 2010-06-22 17:26:01 NMT MEDICAL INC NMTI GLENHILL CAPITAL MANAGEMENT LL various various 10% owner 500,000 $0.76 $382,300.00 2,109,360 view
NMTI declined 400% last week, an absurd overreaction to PRELIMINARY results that were OVERALL POSITIVE:
-STARFlex provided SMALL BENEFIT OVER CURRENT BEST MEDICAL THERAPY and maintained an excellent safety profile. NMTI is discussing next steps with the FDA.
-55% of float owned by institutions. "Available float" only 7 million shares.
-Insiders have purchased over 800,000 shares at prices over $2 in last 6 months.
-The most successful U.S. hedge fund- Renaissance Technololgies, owns NMTI. Renaissance has an army of engineers and MBA's scouring for undervalued stocks.
-In may, the NMTI RT2 Delivery System was lauched in France and will be launched all throughout Europe over the next few months. http://finance.yahoo.com/news/NMT-Medica...
-NMTI Owns or licenses 136 patents, relating to structural heart repair implant technologies and other related cardiovascular implant technologies.
SmarTrend's Trend Spotter See Continued Upward Momentum on Shares of NMT Medical (NMTI) Written on Mon, 01/03/2011 - 10:03am By Chip Brian
SmarTrend is monitoring the recent change of momentum in NMT Medical. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of NMT Medical in search of a potential trend change. In the past 52 weeks, shares of NMT Medical have traded between a low of $0.20 and a high of $4.99 and are now at $0.42, which is 109% above that low price. NMT Medical is currently above its 50-day moving average of $0.28 and should find resistance at its 200-day moving average of $1.43. Look for these moving averages to climb to confirm the company's upward momentum. In the last five trading sessions, the 50-day MA has fallen 0.56% while the 200-day MA has slid 5.21%. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of NMT Medical shares.
NMT Medical, Inc. (NASDAQ: NMTI) today announced that it has entered into a credit agreement with LSQ Funding Group, L.C., a Florida-based firm that specializes in providing financing to small- and medium-sized businesses.
The asset-based credit facility provides for borrowings up to $2 million for working capital requirements and other general corporate purposes. The credit facility has a one-year term and is subject to a borrowing base calculated as a percentage of domestic accounts receivable that are pledged as collateral against the loan.
Richard E. Davis, NMT's Chairman, President and Chief Executive Officer, said, "This non-equity based credit facility, which replaces the credit arrangement with Silicon Valley Bank that we recently terminated, provides NMT with the necessary working capital required to fund its ongoing operations. We continue to tightly manage our expenses while working closely with the U.S. Food and Drug Administration to evaluate our potential next steps relating to patent foramen ovale (PFO) treatment for the stroke and transient ischemic attack (TIA) indications. In addition, we are continuing to evaluate all strategic options."